Literature DB >> 7968282

Bone marrow MRI: techniques and accuracy for detecting breast cancer metastases.

F W Flickinger1, S M Sanal.   

Abstract

We investigated the utility of bone marrow MRI for diagnosing marrow metastases from breast cancer compared with radionuclide bone scan, iliac crest marrow biopsy with histology and antibody immunostaining, and clinical follow-up. We report the results of 43 MRI studies in 32 patients and discuss the evolution and comparison of optimal MRI techniques. MRI appears to be the most accurate diagnostic method, and short TI Inversion Recovery (STIR) the most reliable pulse sequence for this group of patients with breast cancer.

Entities:  

Mesh：

Year:  1994        PMID： 7968282     DOI： 10.1016/0730-725x(94)92023-0

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN： 0730-725X            Impact factor:   2.546


  11 in total

1.  MRI detection of early bone metastases in b16 mouse melanoma models.

Authors:  Karen M Gauvain; Joel R Garbow; Sheng-Kwei Song; Angela C Hirbe; Katherine Weilbaecher
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  Management of breast cancer in pregnancy.

Authors:  Richard Theriault; Karin Hahn
Journal:  Curr Oncol Rep       Date:  2007-01       Impact factor: 5.075

3.  Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review.

Authors:  Sarah Kalus; Asif Saifuddin
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

Review 4.  Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer.

Authors:  Michael A Jacobs; Li Pan; Katarzyna J Macura
Journal:  Semin Roentgenol       Date:  2009-04       Impact factor: 0.800

5.  Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.

Authors:  K Engelhard; H P Hollenbach; K Wohlfart; E von Imhoff; F A Fellner
Journal:  Eur Radiol       Date:  2003-07-05       Impact factor: 5.315

6.  Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.

Authors:  A Stecco; G Romano; M Negru; D Volpe; A Saponaro; S Costantino; G Sacchetti; E Inglese; O Alabiso; A Carriero
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

7.  Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.

Authors:  Mehmet Halit Yilmaz; Mustafa Ozguroglu; Devrim Mert; Hande Turna; Gökhan Demir; Ibrahim Adaletli; Sila Ulus; Metin Halac; Kaya Kanberoğlu
Journal:  Med Oncol       Date:  2007-11-27       Impact factor: 3.064

8.  Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.

Authors:  Sandip Basu; Drew Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 10.057

9.  False-positive technetium-99m methylene diphosphonate bone scan activity in the orbit in a patient with a history of breast carcinoma.

Authors:  Sarah E Bonnet; Joel R Palko
Journal:  World J Nucl Med       Date:  2018 Oct-Dec

10.  Evaluation of Response to Therapy in a Patient with Lung Cancer: Correlation of Sclerotic Bone Lesions with F 18 FDG PET/CT and Bone Scintigraphy.

Authors:  Tamer Ozülker; Filiz Ozülker; Aysun Küçüköz Uzun; Tarık Tatoğlu; Tevfik Ozpaçacı
Journal:  Mol Imaging Radionucl Ther       Date:  2011-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.